2011 High-Throughput Chemistry and Chemical Biology Gordon Research Seminar
2011 High-Throughput Chemistry and Chemical Biology Gordon Research Seminar
批准号:
8189545
负责人:
William Charles Krause Pomerantz
金额:
$0.2万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-06-01 至 2012-05-31
关键词:
AddressAreaBiochemistryBiological ProcessBiologyBusinessesChemicalsChemistryCollaborationsCoupledDevelopmentDisciplineEmerging TechnologiesEnvironmentEvaluationFeedbackFertilizationFosteringGoalsGovernmentInfusion proceduresLaboratoriesLeadLocationMentorshipMethodsMolecular BankMolecular BiologyParticipantPharmaceutical ChemistryPositioning AttributePostdoctoral FellowProtein EngineeringResearchResearch PersonnelScientistScreening procedureSenior ScientistShapesSiteSocial InteractionStudentsSynthesis ChemistryTalentsTechnologyTimeUniversitiesVeteransWritingbasecareercareer developmentcollegedesigndrug discoveryfrontiergraduate studentinnovationmultidisciplinarypeerpostersprofessorprogramssocialsuccesssymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The Gordon Research Seminar (GRS) for High-Throughput Chemistry and Chemical Biology is a two-day conference designed to highlight the state-of-the-art advances in high-throughput methods for new screening technologies, high-quality molecular library development and cross-disciplinary chemical biology methods to unite the fields of synthetic chemistry and molecular biology. The goal of the GRS is to promote the research of early career scientists and develop the next leaders in the field of drug discovery. A successful scientific program, effective professional development, and synergistic interactions between early career scientists and senior researchers will be achieved through three specific aims: (1) Development of a cutting-edge scientific program presenting recent advances from the fields of high-throughput chemistry and chemical biology. (2) Creation of mentorship/career opportunities for early career scientist (3) Promotion of increased and sustained scientific discourse between GRS and GRC participants for fostering new innovative ideas in the area of drug discovery. The GRS features presentations by graduate students and postdoctoral researchers who are emerging leaders in their respective fields. Attendance of the GRS is capped at 50 participants. The intimate size and location of a GRS provides an environment for junior scientists to present their research to their immediate peers facilitates spirited scientific discourse and encourages participation throughout the duration of both the GRS and the Gordon Research Conference (GRC) to immediately follow. The two-day scientific program will include three scientific sessions and two poster sessions. Ten scientific talks will be presented with adequate time for discussion. All presentations will be by graduate students or postdoctoral researchers with the exception of a Keynote address by Professor Jim Wells, (UCSF), an internationally recognized leader in protein engineering, biochemistry, and drug discovery. To foster interactions with senior researchers, each session will be co-chaired by a senior research scientist and either a graduate student or postdoctoral researcher. Finally, a formal professional development/ career panel will conclude the conference. The panel will be composed of academics, industrial scientists and a postdoctoral research fellow.
PUBLIC HEALTH RELEVANCE: Drug discovery benefits from a continual infusion of new ideas from many disciplines associated with this field specifically including the disciplines of high- throughput chemistry and chemical biology. Further, continued progress and sustained innovation for the field requires a continuous influx of new scientists contributing new ideas and becoming integrated into the field of drug discovery. The Gordon Research Seminar (GRS) provides such a forum, by bringing in graduate student and postdoctoral researchers to present the latest results in their respective fields, and encourages their scientific development through formal mentorship/career development components.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chemical Probe Development for Epigenetic Complexes Enabled by Protein-Observed 19F NMR
-
批准号:10796381
-
项目类别:
-
资助金额:$9.49万
-
财政年份:2021
-
负责人:William Charles Krause Pomerantz
-
依托单位:
Chemical Probe Development for Epigenetic Complexes Enabled by Protein-Observed 19F NMR
-
批准号:10375536
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2021
-
负责人:William Charles Krause Pomerantz
-
依托单位:
Chemical Probe Development for Epigenetic Complexes Enabled by Protein-Observed 19F NMR
-
批准号:10165958
-
项目类别:
-
资助金额:$36.2万
-
财政年份:2021
-
负责人:William Charles Krause Pomerantz
-
依托单位:
Chemical Probe Development for Epigenetic Complexes Enabled by Protein-Observed 19F NMR
-
批准号:10554380
-
项目类别:
-
资助金额:$38.23万
-
财政年份:2021
-
负责人:William Charles Krause Pomerantz
-
依托单位:
Small Molecule Transcriptional Activator-Coactivator Interactions
-
批准号:8013603
-
项目类别:
-
资助金额:$5.13万
-
财政年份:2010
-
负责人:William Charles Krause Pomerantz
-
依托单位:
Small Molecule Transcriptional Activator-Coactivator Interactions
-
批准号:7806222
-
项目类别:
-
资助金额:$4.76万
-
财政年份:2010
-
负责人:William Charles Krause Pomerantz
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: